4-(3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)morpholine, 95.0%, 5g

2,4-Dichloro-8-methylquinazoline, 95.0%, 10g

3-Fluorophthalic anhydride, 97.0%, 100g

4-[(Chloroacetyl)amino]-3-methylbenzoic acid, 95.0%, 1g

ethyl 4-(1-methyl-1H-pyrrol-2-yl)-2,4-dioxobutanoate, 95.0%, 10g

(2-Fluoro-5-(morpholine-4-carbonyl)phenyl)boronic acid, 95.0%, 1g

Isopropyl palmitate, min. 90%, for synthesis, 1 l, plastic packaging.

5-(Aminomethyl)piperidin-2-one, 95.0%, 10g

(5-Methylpyridin-2-yl)boronic acid, 95.0%, 1g

5-Furan-2-yl-1H-pyrazole-3-carboxylic acid ethyl ester, 95.0%, 1g

4-Amino-N-(5-chloro-2-methylphenyl)benzamide, 97%, 5g

(S)-1-tert-Butyl 2-ethyl 5-oxopiperidine-1,2-dicarboxylate, 95.0%, 250mg

8-Fluoro-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylic acid, 97.0%, 1g